Journal of Nutrition EB Program 2010 Abstracts

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supporting Material
Right arrow Online Supporting Material
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, J.
Right arrow Articles by Ordovas, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, J.
Right arrow Articles by Ordovas, J. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Dietary Fats
*Metabolic Syndrome
© 2007 American Society for Nutrition J. Nutr. 137:1846-1851, August 2007


Biochemical, Molecular, and Genetic Mechanisms

Interleukin1ß Genetic Polymorphisms Interact with Polyunsaturated Fatty Acids to Modulate Risk of the Metabolic Syndrome1–3,

Jian Shen4, Donna K. Arnett5, James M. Peacock6, Laurence D. Parnell4, Aldi Kraja7, James E. Hixson8, Michael Y. Tsai9, Chao-Qiang Lai4, Edmond K. Kabagambe5, Robert J. Straka10 and Jose M. Ordovas4,*

4 Nutrition and Genomics Laboratory, JM-U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111; 5 Department of Epidemiology, University of Alabama, Birmingham, AL 35294; 6 Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN 55415; 7 Division of Statistical Genomics, Washington University School of Medicine, St. Louis, MO 63110; 8 Human Genetics Center, University of Texas, Houston, TX 77225; 9 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55415; and 10 Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN 55455

* To whom correspondence should be addressed. E-mail: jose.ordovas{at}tufts.edu.

Chronic inflammation has been identified as an important component of the metabolic syndrome (MetS). Therefore, environmental and genetic factors contributing to the variation of inflammatory responses could affect individuals' susceptibility to MetS. We investigated the association between common IL1ß genetic polymorphisms, inflammation, and the MetS, and the modulation of diet-related variables (i.e., erythrocyte membrane fatty acid composition) in a white U.S. population. IL1ß single nucleotide polymorphisms (SNP) (–1473G > C, –511G > A, –31T > C, 3966C > T, 6054G > A), clinical and biochemical measurements were characterized in a total of 1120 subjects (540 males and 580 females) participating in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study. The 6054 G > A SNP was significantly associated with plasma C-reactive protein (P = 0.054), adiponectin (P = 0.021), and the prevalence of MetS (P = 0.004). Moreover, there was a significant interaction between the 6054G > A SNP and erythrocyte membrane (n-3) PUFA (P = 0.019). Among subjects with low (n-3) PUFA content (below the median), the 6054 G allele was associated with increased risk of the MetS (OR = 3.29, 95%CI = 1.49–7.26 for GG and OR = 1.95, 95%CI = 0.85–4.46 for GA, P < 0.001) compared with the AA genotype, but there were no significant genotype associations among subjects with high (n-3) PUFA content (above the median). Further analyses supported a significant haplotype global effect on the MetS (P = 0.017) among subjects with low (n-3) PUFA content. These results suggested that IL1ß genetic variants were associated with measures of chronic inflammation and the MetS risk, and that genetic influences were more evident among subjects with low (n-3) PUFA intake.





This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. Garaulet, Y.-C. Lee, J. Shen, L. D Parnell, D. K Arnett, M. Y Tsai, C.-Q. Lai, and J. M Ordovas
CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids
Am. J. Clinical Nutrition, December 1, 2009; 90(6): 1466 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. W. P. Koppe, M. Elias, R. H. Moseley, and R. M. Green
Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet
Am J Physiol Gastrointest Liver Physiol, August 1, 2009; 297(2): G378 - G384.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel
The Metabolic Syndrome
Endocr. Rev., December 1, 2008; 29(7): 777 - 822.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Shen, D. K. Arnett, P. Perez-Martinez, L. D. Parnell, C.-Q. Lai, J. M. Peacock, J. E. Hixson, M. Y. Tsai, R. J. Straka, P. N. Hopkins, et al.
The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN study,boxs
J. Lipid Res., August 1, 2008; 49(8): 1839 - 1845.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2007 by American Society for Nutrition